Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. Cost is an important final factor, especially for small and mid-sized pharma companies. As such, NeoFlex plungers are ideal for highly sensitive, large molecule drugs. A new challenge

Packaging 130

Packaging Packaging Vaccination Vaccine 130

Delveinsight

FEBRUARY 14, 2021

Pharmaceutical companies sell their orphan drugs at astronomical prices such that many patients are not able to afford them. Past years saw an increase in the entry of Orphan drugs in the market – at higher rates than ever before, and it is hurting the families and patients. Funding is an issue!

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

pharmaphorum

AUGUST 2, 2022

The current crop of approved PD-1/PD-L1 inhibitors headed by Merck & Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab) are all given IV , and have mainly jostled for market share based on their clinical indications. And BMS is also running late-stage trials of injectable Opdivo, so the race is on.

Trials 98

Trials Marketing Drugs Pharma Companies 98

pharmaphorum

JULY 1, 2021

” The tie-up with neuroloop and B Braun will bring together their expertise in this area with Merck’s knowhow in “electronics, medicines and drug delivery,” he added.

Drug Delivery 94

Drug Delivery Pharma Companies Clinical Development Development 94

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. DS: The company now has clients across big pharma. To what do you attribute your success?

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52